314 Phase 1 study of abemaciclib, a CDK 4 and 6 inhibitor, as a single agent for Japanese patients with advanced cancerS. Kondo,N. Yamamoto,K. Tamura,Y. Tanabe,S. Iwasa,A. Shimomura, Y. Shibasaki,K. Ogasawara, K. Turner-Jones, J. Mori,H. Asou,E. Michael Chan,Y. FujiwaraEUROPEAN JOURNAL OF CANCER(2015)引用 3|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要